EUVIMEDEUVIMED entdecken
Open Access

Middle East Respiratory Syndrome Coronavirus Infection Elicits Long-lasting Specific Antibody, T and B Cell Immune Responses in Recovered Individuals

Rowa Y Alhabbab, Abdullah Algaissi iD, Ahmed Bakr Mahmoud, Almohanad A Alkayyal, Sawsan Al-Amri, Mohamed A Alfaleh, Mohammad Basabrain, Roua Abdullah Alsubki, Ibrahim S Almarshad, Abdulelah M Alhudaithi, Omar A Al Gafari, Yasser A Alshamlan und 7 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Rowa Y Alhabbab und 18 weiteren Autor:innen. Beteiligte Einrichtung: Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Coronavirus Infections, Middle East Respiratory Syndrome Coronavirus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic zoonotic betacoronavirus and a global public health concern. Better undersetting of the immune responses to MERS-CoV is needed to characterize the correlates of protection and durability of the immunity and to aid in developing preventative and therapeutic interventions. Although MERS-CoV–specific circulating antibodies could persist for several years post-recovery, their waning raises concerns about their durability and role in protection. Nonetheless, memory B and T cells could provide long-lasting protective immunity despite the serum antibodies levels.

Methods

Serological and flow cytometric analysis of MERS-CoV–specific immune responses were performed on samples collected from a cohort of recovered individuals who required intensive care unit (ICU) admission as well as hospital or home isolation several years after infection to characterize the longevity and quality of humoral and cellular immune responses.

Results

Our data showed that MERS-CoV infection could elicit robust long-lasting virus-specific binding and neutralizing antibodies as well as T- and B-cell responses up to 6.9 years postinfection regardless of disease severity or need for ICU admission. Apart from the persistent high antibody titers, this response was characterized by B-cell subsets with antibody-independent functions as demonstrated by their ability to produce tumor necrosis factor α (TNF-α), interleukin (IL)-6, and interferon γ (IFN-γ) cytokines in response to antigen stimulation. Furthermore, virus-specific activation of memory CD8+ and CD4+ T cell subsets from MERS-recovered patients resulted in secretion of high levels of TNF-α, IL-17, and IFN-γ.

Conclusions

MERS-CoV infection could elicit robust long-lasting virus-specific humoral and cellular responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronavirus InfectionsMiddle East Respiratory Syndrome CoronavirusHumansAntibodies, NeutralizingAntibodies, ViralImmunity, CellularInterferon-gammaTumor Necrosis Factor-alphaT-LymphocytesB-Lymphocytes

Stichwörter der Autor:innen

MERS-CoVT cellsantibodiescoronavirusesimmunitylongevity

Substanzen

Antibodies, NeutralizingAntibodies, ViralInterferon-gammaTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.
  • Department of Medical Laboratory Technology, College of Applied Medical Sciences, Taibah University, Almadinah Almunwarah, Saudi Arabia.
  • Department of Medical Laboratory Technology, College of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia.
  • Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.

ORCID-Profile: Abdullah Algaissi, Anwar M Hashem

Zitieren

APA

Alhabbab, R. Y., Algaissi, A., Mahmoud, A. B., Alkayyal, A. A., Al-Amri, S., Alfaleh, M. A., Basabrain, M., Alsubki, R. A., Almarshad, I. S., Alhudaithi, A. M., Gafari, O. A. A., Alshamlan, Y. A., Aldossari, H. M., Alsafi, M. M., Bukhari, A., Bajhmom, W., Memish, Z. A., Al Salem, W. S., & Hashem, A. M. (2023). Middle East Respiratory Syndrome Coronavirus Infection Elicits Long-lasting Specific Antibody, T and B Cell Immune Responses in Recovered Individuals. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac456

Vancouver

Alhabbab RY, Algaissi A, Mahmoud AB, Alkayyal AA, Al-Amri S, Alfaleh MA, et al. Middle East Respiratory Syndrome Coronavirus Infection Elicits Long-lasting Specific Antibody, T and B Cell Immune Responses in Recovered Individuals. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac456

BibTeX
@article{Alhabbab2023,
  author = {Alhabbab, Rowa Y and Algaissi, Abdullah and Mahmoud, Ahmed Bakr and Alkayyal, Almohanad A and Al-Amri, Sawsan and Alfaleh, Mohamed A and Basabrain, Mohammad and Alsubki, Roua Abdullah and Almarshad, Ibrahim S and Alhudaithi, Abdulelah M and Gafari, Omar A Al and Alshamlan, Yasser A and Aldossari, Hassan M and Alsafi, Mohammed M and Bukhari, Abdullah and Bajhmom, Wael and Memish, Ziad A and Al Salem, Waleed S and Hashem, Anwar M},
  title = {Middle East Respiratory Syndrome Coronavirus Infection Elicits Long-lasting Specific Antibody, T and B Cell Immune Responses in Recovered Individuals},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac456}
}
Kostenlos starten →